Company / AR per Share
Xenon Pharmaceuticals Inc. AR per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.02
FY2024
5-year range
$0.01 / $0.06
FY2020-FY2024
Trend
+44.3%
vs FY2023
Sector context
#103 of 113
Health Care
What the data says
Among 113 Health Care companies, Xenon Pharmaceuticals Inc. is in the bottom 9% for ar per share. AR per Share returned to growth in FY2024 after 2 years of decline, reaching $0.02.
Based on SEC 10-K filings.
0.02 in FY2024 with a 5-year CAGR of -9.7%.
Improved from $0.02 to $0.02 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- -33.2%
- 5-Year CAGR
- -9.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 113This company $0.02 Sector average $28.83
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2024, ar per share increased 44.3% year-over-year.
- Ranks #103 out of 113 companies in the Health Care sector.
- Peak ar per share was recorded in FY2021.
- Lowest ar per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.51 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0.02 | +44.3% |
| FY2023 | $0.01 | -19.8% |
| FY2022 | $0.02 | -74.3% |
| FY2021 | $0.06 | +20.2% |
| FY2020 | $0.05 | +68.3% |
| FY2019 | $0.03 | +273.6% |
| FY2018 | $0.01 | -65.7% |
| FY2017 | $0.02 | +75.7% |
| FY2016 | $0.01 | -37.4% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026